Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Cell Therapy Processing Market Growth From $5.92 Billion In 2026 To $9.93 Billion By 2030 At A CAGR Of 13.8%

The cell therapy processing sector has experienced substantial expansion recently, with its market value projected to increase from $5.18 billion in 2025 to $5.92 billion in 2026, reflecting a compound annual growth rate of 14.3%. This upward trajectory in the preceding timeframe was driven by a confluence of factors including a surge in clinical trials for cell-based treatments, enhancements in biopharmaceutical production capabilities, the proliferation of dedicated processing infrastructures, a heightened level of proficiency in good manufacturing practice (GMP) adherence, and escalating investments in cutting-edge therapeutic modalities.

The cell therapy processing market is poised for substantial expansion over the next several years, projecting a rise to $9.93 billion by 2030 with a compound annual growth rate (CAGR) of 13.8%. This projected increase is fueled by several key factors, including the escalating commercial availability of gene and cell therapies, a heightened need for contract manufacturing solutions, the proliferation of distributed manufacturing approaches, wider implementation of digital quality management systems, and an uptick in regulatory endorsements for cell-based therapeutic interventions. Key developments anticipated during this forecast period encompass the greater utilization of GMP-compliant processing platforms, a surge in the demand for adaptable cell therapy production capabilities, increased integration of automated workflow software, the broadening of contract processing services, and a reinforced emphasis on maintaining sterility and assuring quality throughout the manufacturing process.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

Cell Therapy Processing Market Demand Drivers: What Is Fueling Industry Growth?

The proliferation of research endeavors in the realm of cell therapy is anticipated to be a significant catalyst for the expansion of the cell therapy processing market. Cell therapy itself is defined as the production of medicinal products utilizing live cells, aimed at addressing or alleviating a spectrum of ailments such as cancers, autoimmune diseases, and inherited disorders. A key driver behind the escalating demand for cell-based therapeutics is the pressing requirement for manufacturing systems that are both adaptable and dependable, capable of sustaining substantial cell concentrations while preserving the integrity of the final product. The processing of cells plays a crucial role in advancing cell therapy research by facilitating uniform preparation, rigorous quality assurance, and the large-scale production of superior quality cells, thereby guaranteeing dependable and repeatable results for both investigative activities and clinical trials. As an illustration, by December 2024, the International Federation of Pharmaceutical Manufacturers and Associations, an organization headquartered in Switzerland, reported that six novel cell and gene therapies, representing first-in-class innovations, were launched in 2023, a noteworthy increase of 50% compared to the three such treatments launched in 2022. Consequently, the heightened volume of research activities in cell therapy is directly fueling the growth trajectory of the cell therapy processing market.

Cell Therapy Processing Market Segment Landscape: Which Areas Lead Market Development?

The cell therapy processing market covered in this report is segmented –

1) By Offering Type: Products, Services, Software

2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

Subsegments:

1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

Cell Therapy Processing Market Innovation Trends: Which Developments Are Transforming The Industry?

The leading enterprises within the cell therapy processing sector are dedicated to creating sophisticated technologies, for example, combined bioreactor-centrifuge apparatuses, which serve to optimize production sequences and enhance the reliability, adaptability, and aseptic conditions of treatments derived from cells. This integrated bioreactor-centrifuge unit represents a singular piece of equipment merging cell cultivation and centrifugation for separation into one contained module, facilitating uninterrupted, automated cell treatment processes without the necessity of moving cells between different stages. As an illustration, in March of 2025, Limula SA, a firm based in Switzerland specializing in the production of cell and gene therapies (CGT), introduced LimONE, a fully automated, enclosed platform designed for cell therapy production. This pioneering system assimilates physical components, disposable supplies, and software guided by predetermined protocols to simplify intricate cell processing stages, including incubation, centrifugation, and the management of chemical agents, all within a solitary, space-efficient assembly, thereby allowing for uniform, scalable output of therapies like CAR-T and genetically modified stem cells, from initial research phases up to Good Manufacturing Practice (GMP) compliant industrial levels, while circumventing the complexities associated with technology transfers.

Cell Therapy Processing Market Industry Leaders And Market Competition

Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

Access The Complete Cell Therapy Processing Market Report:

https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

Cell Therapy Processing Market Leading Geography: Which Region Generates The Most Revenue?

North Americawas the largest region in the cell therapy processing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model